Sign inJoin waitlistJoin the waitlist

Justin Hewlett

And Director, Interstitial Lung Disease Program · Vanderbilt University Medical Center

Credentials: · · · · ·

History

Vanderbilt University Medical Center
Present

Pulmonary Disease and Critical Care Medicine
Vanderbilt University Medical Center
2016–2019
Internal Medicine
Vanderbilt University Medical Center
2012–2015
Univ of Florida Coll of Med
2008–2012
University of Florida
2004–2008

Research

Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets
Review · Matrix Biology · 2018 · First of 3 authors · 261 citations
A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening
Review · Journal of Inherited Metabolic Disease · 2006 · First of 2 authors · Corresponding · 122 citations
Foreign body aspiration in adult airways: therapeutic approach
Review · Journal of Thoracic Disease · 2017 · First of 5 authors · 106 citations

JK
Jonathan Kropski
4 papers
Fabien Maldonado
3 papers
Timothy Blackwell
3 papers
Erica Ludtke
2 papers
Erin Wilfong
2 papers
JL
James Loyd
2 papers
Lisa Lancaster
2 papers
Margaret Salisbury
2 papers
Otis Rickman
2 papers
Robert Lentz
2 papers · 2 as a fellow
Adam Guttentag
1 paper
Adenrele Olajide
1 paper

Clinical trials

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Site PI · Recruiting · Phase 2
Avalyn Pharma Inc.
2025–2031
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Site PI · Recruiting · Phase 3
United Therapeutics
2023–2027
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Site PI · Recruiting
Duke University
2014–2031